Eric Benevich sold $251K of Neurocrine Biosciences (NBIX)

Executed Feb 13 2025, disclosed Feb 14 2025, 1 day later.

Value, as filed

$251K

2,154 sh across 2 lots

Executed

Feb 13 2025

the trade date, as filed

Disclosed

Feb 14 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

EB Eric Benevich Chief Commercial Officer profile →

Eric Benevich (Chief Commercial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $906K of NBIX (5,970 sh × $151.74, as filed), executed Nov 28 2025.

The name

NBIX Neurocrine Biosciences, Inc. NBIX · Healthcare · 59 filings in 24 months ticker →

Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Eric Benevich in NBIX

NBIXSALE Neurocrine Biosciences, Inc. $333K
2,154 sh × $154.61
Exec Sep 9
Filed Sep 10 · 8:29 PM ET NBIXSALE Neurocrine Biosciences, Inc. $906K
5,970 sh × $151.74
Exec Nov 28 2025
Filed Dec 2 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $116K
980 sh × $118.31
Exec Feb 10 2025
Filed Feb 12 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $185K
1,207 sh × $152.94
Exec Jan 31 2025
Filed Feb 4 2025 · 5:30 PM ET